A patient with homozygous p thalassemia of Germadtalian descent was found to be doubly heterozygous for the common IVSI-110 G -+ A mutation of the p globin gene and for a novel C -+ T mutation of the proximal CACCC-box of the p globin gene promoter at position -87 relativeto the transcription start site (cap). Transcription analysis in an HeLa cell transfection assay indicated a 45% to 51% residual activity of the gene with the -87 C -+ T mutation relative to normal, further underlining the physiologic role of the affected promoter element. The finding of an only moderately reduced HE CLINICAL picture of homozygous p thalassemia is T characterized by a severe anemia that usually becomes transfusion dependent in early childhood.' Atypically mild courses of the illness can result from the coinheritance of 01 thalassemia' or from mutations causing the hereditary persistence of fetal hemoglobin ~ynthesis.~ A mild clinical phenotype can also result from mutations that allow a high residual activity of the p globin gene. Some such changes can be found in the less stringently conserved nucleotides of the splice consensus sequences:' Others are located at transcription factor binding sites within the promoter region, resulting in a reduced efficiency of transcription initiati~n.'~ "
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We describe here a patient of GermadItalian descent with thalassemia intermedia who is doubly heterozygous for the common IVSl position 110 G -+ A mutation and for a novel C + T mutation at position -87 relative to the transcription start site (cap). This -87 mutation affects the proximal CACCC element of the p globin gene promoter and reduces th; amount of RNA accumulated in an HeLa cell transfection assay to about half the normal level. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section I734 solely to indicate this fact. o 1991 by The American Society of Hematology.
MATERIALS AND METHODS

Hemoglobin
-y, @p, and p globin gene probes.22 In addition to the p haplotype, digests with all the above enzymes plus PstI, XbaI, and EcoRI were hybridized with all the probes mentioned to perform a more detailed gene mapping of the p globin gene locus.
The mutations of the p globin genes were determined after polymerase chain reaction (PCR) amplification2' of a portion of the p globin gene using 24mer oligonucleotides as primers (5'-TATGCTTACCAAGCTGTGATTCCA-3'; 5 ' -CCCCTTCCTATGACATGAACTTAA-3') and Taq DNA polymerase purchased from Pharmacia (Uppsala, Sweden) using buffers as recommended by the manufacturer. The temperatures and times of the three PCR steps in a total of 30 cycles were 95"C156"C171"C and 30 seconds160 seconds190 seconds, respectively. The presence of mutations at particular positions was detected by allele-specific oligonucleotide hybridization of dot-blotted amplified DNA using '*P-endlabeled 20-bp oligonucleotides of the wild type or of the mutated sequence as probes.24 Hybridization and washing was performed in a buffer containing tetra-methylammonium chloride.z5
DNA sequencing was performed on asymmetrically PCRamplified DNA (primer ratio of 50:l) using one of the amplification primers as the primer for the sequencing reaction26 and on plasmid DNA using standard protocols.
The expression vector used was based on the plasmid pSP65 and includes the SV40 enhancer sequences and the Herpes simplex virus type 1 (HSV1) thymidine kinase (TK) gene. Into this vector a 5.0-kb BglII fragment was inserted containing the entire p globin gene.' A PCR-amplified p globin gene fragment containing the promoter mutation was cleaved with the restriction enzymes HpaI and BamHI and introduced into the expression vector to substitute for the corresponding wildtype sequence. Fifty micrograms of supercoiled recombinant DNA was introduced into HeLa cells by calcium phosphate precipitation." The cells were harvested after 48 hours and the RNA extracted by guanidinium isothyonate lysis and centrifugation through a CsCl cushion. RNA analysis was performed by ribonuclease protection of single-stranded riboprobes" using an EcoRIIPstI 3'p globin and a 740-bp PstIIPvuII 3'HSVl TK gene fragment in pSP64 or pSP65 as templates. The relative quantities of accumulated RNA were estimated by scintillation counting of the protected RNA fragments contained in cut gel slices of a standardized size.
The now 20-year-old male patient was initially diagnosed to have homozygous p thalassemia intermedia at the age of 5 years when he was admitted to the hospital because of a head injury. A blood count showed a marked hypochromic microcytic anemia (Hb 9. (Fig 1) and massive hepatosplenomegaly. During the past 2 years the transfusion frequency has been increasing to about six per year; this increase is probably related to hypersplenism.
An analysis of the ethnically German mother showed minimal anemia (Hb 12.4 g/dL, Hk 38%) with slightly hypochromic and microcytic red blood cell indices (MCV 84 fL, MCH 26%) and increased HbA, (5.5%) and HbF (3.4%). The Italian father was not available for study.
RESULTS
a globin gene mapping demonstrated a normal complement of four a globin genes (adaa) in the propositus and his mother.
The patient and his mother are both homozygous for the common Caucasian haplotype I." 
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mutations detected the IVSl position 110 G + A mutation on one allele of the propositus, but was not found in the mother's DNA (not shown). Therefore, this mutation is likely to be of paternal origin.
Direct sequencing of the patient's PCR-amplified DNA showed the heterozygous inheritance of a thus far undescribed C + T mutation at position -87 relative to the transcription start site (cap) affecting the proximal CACCC promoter element (Fig 2) . A pair of o1igonucleoti;iks containing the wild type or the mutated sequence at this position was synthesized and hybridized to independently amplified samples of the propositus and his mother. This analysis confirmed/demonstrated the presence of the -87 C + T mutation in both samplcs (Fig 3) . The patient is thus doubly heterozygous for this novel mutation of the p globin gene promoter and one of the common Mediterranean p thalassemia mutations (-87 C + T/IVS1-110 G + A). Sequencing of the entire p globin gene contained in the vector used for transcription analysis showed the normal sequence except for the -87 C + T mutation.
The functional effect of the -87 C + T mutation was investigated by comparing the transcription of the mutated with the wildtype gene in transfected HeLa cells (Fig 4) . (Table 1) . However, the phenotype of affected patients appears variable. The -29 A + G, the -30 T + A, and the -31 A + G mutations are associated with a relatively mild clinical picture in homozygous patients, whereas the -28 A + C mutation was found in a patient with transfusiondependent thalassemia major ( Table 1 ). The reason for the discrepancy between the phenotypic effect and the behavior of the -28 A + C gene in transfected cells is not clear. A mutation at position -101 relative to cap, ie, in the distal CACCC-box, results in a particularly mild form of p thalassemia that does not produce any hematologic abnormalities in the heterozygote (silent p thalassemia), and in compound with another more severe p thalassemia mutation produces only moderate a~~emia.'~.'~ Mutations of the proximal CACCC-box have been described at position -87 (C + G)" and at position -88 (C + T).I3 The -88 mutation and the -87 C + G mutations are associated with a mild clinical phenotype of homozygous p thalassemia."" Transcription analysis of these mutated genes indicated a residual activity of between 20% and 30% relative to r10rmal.l~ The -87 C + T mutation of the proximal CACCC-box described here results in a residual activity of about 45% to 51% relative to a normal gene in an HeLa cell transcription assay. This finding correlates with the remarkably mild clinical phenotype in the patient with homozygous p thalassemia and with the only slight hematologic changes in his heterozygous mother. However, it was surprising to find an HbA, level of 5.5% in the mother, as the increased HbA, in heterozygous p thalassemia is thought to be due to the lack of p chains, thus promoting the low-affinity binding of excess a with 6 globin chains. Therefore, one might have expected a lower HbA, level in a heterozygote for the -87 C + T mutation.
The differences in the behavior between genes carrying the -87 C + T o r C + G mutations is a further example for the variable effect of different mutations at the same site. It is conceivable that the transversion of a purine base for a -- pyrimidine in the case of the C + G mutation has a more profound effect on the tertiary structure of the DNA than the C + T tran~ition.~' A similar example among the p thalassemia mutations can be found at position 5 of the first intron where transversions of the normal G by a C or a T almost completely inactivate the gene: whereas a G + A transition results in only moderate reduction of splicing efficiency' and a mild clinical phenotype. 6 The cluster of four CACCC-box mutations underlines the likely physiologic significance of that sequence motif in globin gene expression. It is notable in this context that the promoter of the poorly expressed 6 globin gene does not contain this element. It is also remarkable that all the known mutations of the proximal CACCC-box, including that described here, have a more marked effect on p globin gene activity than the -101 mutation of the distal CACCCbox, probably reflecting a more important functional role of the proximal element.
